43 results on '"Delaporte, E."'
Search Results
2. Identification and Molecular Characterization of Subsubtype A4 in Central Africa
- Author
-
Vidal, N., primary, Mulanga, C., additional, Bazepeo, S. Edidi, additional, Lepira, F., additional, Delaporte, E., additional, and Peeters, M., additional
- Published
- 2006
- Full Text
- View/download PDF
3. Phylogenetic Analysis of a New Chimpanzee Lentivirus SIVcpz-gab2 from a Wild-Captured Chimpanzee from Gabon
- Author
-
JANSSENS, W., primary, FRANSEN, K., additional, PEETERS, M., additional, HEYNDRICKX, L., additional, MOTTE, J., additional, BEDJABAGA, L., additional, DELAPORTE, E., additional, PIOT, P., additional, and VAN DER GROEN, G., additional
- Published
- 1994
- Full Text
- View/download PDF
4. Genetic and Phylogenetic Analysis of env Subtypes G and H in Central Africa
- Author
-
JANSSENS, W., primary, HEYNDRICKX, L., additional, FRANSEN, K., additional, MOTTE, J., additional, PEETERS, M., additional, NKENGASONG, J.N., additional, NDUMBE, P.M., additional, DELAPORTE, E., additional, PERRET, J.-L., additional, ATENDER, C., additional, PIOT, P., additional, and VAN DER GROEN, G., additional
- Published
- 1994
- Full Text
- View/download PDF
5. HIV Type 1 pol Gene Diversity and Antiretroviral Drug Resistance Mutations in the Democratic Republic of Congo (DRC)
- Author
-
Vidal, N., Mulanga, C., Bazepeo, S. Edidi, Mwamba, J. Kasali, Tshimpaka, J., Kashi, M., Mama, N., Valéa, D., Delaporte, E., Lepira, F., and Peeters, M.
- Abstract
To study recombination and the natural polymorphism in pol of HIV-1 strains in the Democratic Republic of Congo (DRC) we sequenced the protease and RT genes for 70 HIV-1 strains previously characterized in the env V3–V5 region from a sentinel surveillance study in 2002. For 41 of the 70 (58.6%) strains, the same subtype/ CRF designations were observed in pol and env. Twenty-three (32.9%) of 70 pol sequences were complex recombinants involving two to five subtypes as well as fragments that could not be classified into any of the known subtypes. All subtypes were involved in recombination events. Unclassified (U) and env subtype H strains were very likely to be recombinant strains. Overall, many minor mutations were identified in the protease sequences. Although at the time of our study ARV use was not yet widespread in DRC, three strains were identified with one major mutation associated with drug resistance: L90M and M46L in protease and K103N in RT.
- Published
- 2006
- Full Text
- View/download PDF
6. Short Communication: Nucleoside Reverse Transcriptase Inhibitors with Reduced Predicted Activity Do Not Impair Second-Line Therapy with Lopinavir/Ritonavir or Darunavir/Ritonavir.
- Author
-
Villabona-Arenas CJ, Eymard-Duvernay S, Aghokeng A, Guichet E, Toure-Kane C, Bado G, Koulla-Shiro S, Delaporte E, Ciaffi L, and Peeters M
- Subjects
- Adult, Burkina Faso, Cameroon, Female, Genotype, HIV-1 genetics, HIV-1 isolation & purification, Humans, Male, Senegal, Treatment Outcome, Viral Load, Antiretroviral Therapy, Highly Active methods, Drug Resistance, Viral, HIV Infections drug therapy, HIV Infections virology, HIV Protease Inhibitors therapeutic use, Mutation, Missense, Reverse Transcriptase Inhibitors therapeutic use
- Abstract
Second-line therapy randomized trials with lopinavir/ritonavir question the value of resistance testing to guide nucleoside reverse transcriptase inhibitor (NRTI) selection. In this study, we investigated the association between baseline drug resistance and treatment outcome after 104 weeks of second-line therapy with NRTIs and either darunavir/ritonavir or lopinavir/ritonavir in West-central Africa. We did an observational analysis of data from 387 individuals in a randomized, open-label 2LADY trial in Burkina Faso, Cameroon, and Senegal. We modeled the association between RTI drug resistance mutations (DRMs) and virological failure (VF) (viral load [VL] <50 copies/mL) at week 104 using logistic regressions. Covariates included baseline VL and CD4
+ count, demographic, and adherence data. Overall, 193 (49.9%), 150 (38.8%), and 44 (11.4%) individuals had, respectively, low/none (genotypic susceptibility score [GSS] <1), intermediate (GSS = 1), and high predicted NRTI activity (GSS >1) in their prescribed second-line regimen. The average number of DRMs by drug class, the proportion of individuals by GSS category, and the duration of first-line therapy were not associated with VF (p > .05). High VL at switch was the only consistent prognostic factor for VF after multivariate adjustment (p < .01). Suboptimal adherence, high predicted RTI activity, or low NRTI mutations were associated with VF (p < .05) when using higher end points for VF or in the intention-to-treat analysis. In conclusion, the use of RTIs with predicted reduced activity does not impair second-line protease inhibitor-based therapy. Therefore, HIV care in resource-limited settings should prioritize strategies to improve adherence and targeted VL testing over drug resistance testing for selecting NRTIs during a protease-based second-line switch.- Published
- 2018
- Full Text
- View/download PDF
7. Full Genome Characterization of a New Simian Immune Deficiency Virus Lineage in a Naturally Infected Cercopithecus ascanius whitesidei in the Democratic Republic of Congo Reveals High Genetic Diversity Among Red-Tailed Monkeys in Central and Eastern Africa.
- Author
-
Ahuka-Mundeke S, Mbala-Kingebeni P, Ndimbo-Kumogo SP, Foncelle C, Lunguya-Metila O, Muyembe-Tamfum JJ, Delaporte E, Peeters M, and Ayouba A
- Subjects
- Animals, Computational Biology, Democratic Republic of the Congo, Phylogeny, Simian Immunodeficiency Virus isolation & purification, Whole Genome Sequencing, Cercopithecus virology, Genotype, Simian Acquired Immunodeficiency Syndrome virology, Simian Immunodeficiency Virus classification, Simian Immunodeficiency Virus genetics
- Abstract
Our knowledge on simian immune deficiency virus (SIV) diversity and evolution in the different nonhuman primate species is still incomplete. In this study, we report the full genome characterization of a new SIV from a red-tailed monkey (2013DRC-I8), from the Cercopithecus ascanius whitesidei subspecies, in the Democratic Republic of Congo (DRC). The new full-length genome is 9,926 bp long, and the genomic structure is similar to that of other SIVs with the absence of vpx and vpu genes. The new SIVasc-13DRC-I8 strain fell within the Cercopithecus specific SIV lineage. SIVasc-13DRC-I8 and previously reported SIVrtg from the C.a. schmidti subspecies in Uganda did not form a separate species-specific SIV lineage. These observations provide additional evidence for high genetic diversity and the complex evolution of SIVs in the Cercopithecus genus. More studies on a large number of monkeys from a wider geographic area are needed to understand SIV evolution.
- Published
- 2017
- Full Text
- View/download PDF
8. Short Communication: High Viral Load and Multidrug Resistance Due to Late Switch to Second-Line Regimens Could Be a Major Obstacle to Reach the 90-90-90 UNAIDS Objectives in Sub-Saharan Africa.
- Author
-
Guichet E, Aghokeng A, Serrano L, Bado G, Toure-Kane C, Eymard-Duvernay S, Villabona-Arenas CJ, Delaporte E, Ciaffi L, and Peeters M
- Subjects
- Adult, Burkina Faso epidemiology, Cameroon epidemiology, Female, HIV Infections epidemiology, Humans, Male, Prevalence, Senegal epidemiology, Anti-HIV Agents therapeutic use, Antiretroviral Therapy, Highly Active methods, Drug Resistance, Multiple, Viral, HIV Infections drug therapy, HIV Infections virology, Viral Load
- Abstract
In the context of lifelong antiretroviral treatment (ART) as early as possible and to end the HIV/AIDS epidemic as a public health treat by 2030, it is important to evaluate the potential risk of transmission of HIV-1 drug resistance (HIVDR) in resource-limited countries (RLCs). Since HIV transmission is driven by HIV-1 RNA viral load (VL), we studied the association between plasma VL and HIVDR profiles in 451 adults failing first-line ART from the 2LADY-ANRS12169/EDCTP trial in Burkina Faso, Cameroon, and Senegal. Median duration on first-line ART was 49 months (IQR: 33-69) and 91% patients were asymptomatic. Genotypic drug resistance testing was successful for 446 patients and 98.7% of them were resistant to at least one of the first-line drugs; 40.6% and 55.8% were resistant to two or three drugs of their ongoing first-line ART, respectively. The median VL was higher in patients with HIVDR to all ongoing first-line drugs than in those still susceptible to at least one drug; 4.7 log
10 copies/ml (IQR: 4.3-5.2) versus 4.2 log10 copies/ml (IQR: 3.7-4.7), respectively (p < .001). The proportion of patients with HIVDR to all ongoing first-line drugs was highest (77.9% [95/122]) in patients with VL >5.0 log10 copies/ml. High rates of cross-resistance to other nucleoside reverse-transcriptase inhibitors were observed and were also highest in patients with high VL. Without improvement of patient monitoring to avoid late switch to second-line regimens, a potential new epidemic caused by HIVDR strains could emerge in sub-Saharan Africa and compromise all efforts to reach 90-90-90 UNAIDS objective by 2020.- Published
- 2016
- Full Text
- View/download PDF
9. Challenges of antiretroviral treatment monitoring in rural and remote-access regions in Africa.
- Author
-
Taieb F, Aghokeng AF, Eymard-Duvernay S, Chia JE, Einterz E, Mpoudi-Ngole E, Peeters M, Molina JM, and Delaporte E
- Subjects
- Adult, Africa, Alkynes, Benzoxazines therapeutic use, Cross-Sectional Studies, Cyclopropanes, Female, HIV-1 drug effects, Hospitals, Rural, Humans, Lamivudine therapeutic use, Male, Middle Aged, Nevirapine therapeutic use, Rural Health Services, Rural Population, Stavudine therapeutic use, Treatment Outcome, Zidovudine therapeutic use, Acquired Immunodeficiency Syndrome drug therapy, Anti-HIV Agents therapeutic use, Drug Monitoring, Drug Resistance, Viral genetics, HIV-1 genetics
- Published
- 2014
- Full Text
- View/download PDF
10. HIV type-1 group O infection in Gabon: low prevalence rate but circulation of genetically diverse and drug-resistant HIV type-1 group O strains.
- Author
-
Liégeois F, Boué V, Butel C, Mouinga-Ondémé A, Sica J, Zamba C, Peeters M, Delaporte E, and Rouet F
- Subjects
- Adult, Anti-HIV Agents therapeutic use, Drug Resistance, Viral genetics, Female, Gabon epidemiology, Genetic Variation, Genome, Viral, HIV Infections drug therapy, HIV-1 drug effects, Humans, Male, Middle Aged, Phylogeny, Prevalence, Reverse Transcriptase Inhibitors therapeutic use, HIV Infections epidemiology, HIV Infections virology, HIV-1 classification, HIV-1 genetics
- Abstract
The goals of this study conducted in Gabon were to determine the prevalence rate of HIV-1 group O (HIV-1/O) infections and to characterize the genetic diversity of HIV-1/O strains as well as implications on antiretroviral (ARV) drug resistance. During 2010-2011, 1,176 samples from HIV-positive subjects were tested at the CIRMF (Centre International de Recherches Médicales de Franceville) retrovirology laboratory using an in-house serotyping assay. Plasma HIV-1/O RNA viral loads (VL) were determined using the Abbott RealTime HIV-1 assay. After full genome sequencing, drug resistance patterns were analyzed using two different algorithms (Agence Nationale de Recherches sur le SIDA et les hépatites virales and Stanford). Overall, four subjects (0.34%) were diagnosed as HIV-1/O infected. One subject, untreated by ARVs, died 2 months after HIV-1/O diagnosis. One was lost to follow-up. Two additional patients, treated with nonnucleoside reverse transcriptase inhibitor (NNRTI)-based regimens, showed CD4 counts <200/mm(3) and VL results of 101,000 and 10,050 cp/ml. After full-length genome sequencing of these two strains, we found a wide range of natural polymorphism in the protease (≥15 substitutions) and gp41 (N42D mutation) genes, as well as in the gag and gag-pol cleavage sites. No resistance mutation was detected in the integrase gene. These two strains harbored the Y181C mutation making them resistant to NNRTIs. M41L, M184V, and T215Y mutations were also found for one strain, making it resistant to all NRTIs by the Stanford algorithm. Even if HIV-1/O infection is low in Gabon, an accurate diagnosis and a reliable virological follow-up are required in Central Africa to optimize ARV treatments of HIV-1/O-infected patients.
- Published
- 2013
- Full Text
- View/download PDF
11. Successful integrase inhibitor-based highly active antiretroviral therapy for a multidrug-class-resistant HIV type 1 group O-infected patient in Cameroon.
- Author
-
Aghokeng AF, Kouanfack C, Peeters M, Mpoudi-Ngole E, and Delaporte E
- Subjects
- Anti-HIV Agents administration & dosage, Anti-HIV Agents therapeutic use, Cameroon, Drug Resistance, Multiple, Viral, Female, HIV Infections virology, HIV Integrase Inhibitors administration & dosage, Humans, Middle Aged, Pyrrolidinones administration & dosage, Raltegravir Potassium, Antiretroviral Therapy, Highly Active methods, HIV Infections drug therapy, HIV Integrase Inhibitors therapeutic use, HIV-1 drug effects, Pyrrolidinones therapeutic use
- Published
- 2013
- Full Text
- View/download PDF
12. Identification and molecular characterization of new simian T cell lymphotropic viruses in nonhuman primates bushmeat from the Democratic Republic of Congo.
- Author
-
Ahuka-Mundeke S, Mbala-Kingebeni P, Liegeois F, Ayouba A, Lunguya-Metila O, Demba D, Bilulu G, Mbenzo-Abokome V, Inogwabini BI, Muyembe-Tamfum JJ, Delaporte E, and Peeters M
- Subjects
- Animals, Democratic Republic of the Congo, Genetic Variation, Human T-lymphotropic virus 1 genetics, Humans, Molecular Sequence Data, Phylogeny, Sequence Analysis, DNA, Simian T-lymphotropic virus 1 genetics, Terminal Repeat Sequences genetics, Human T-lymphotropic virus 1 classification, Meat virology, Primates virology, Simian T-lymphotropic virus 1 classification
- Abstract
Four types of human T cell lymphotropic viruses (HTLV) have been described (HTLV-1 to HTLV-4) with three of them having closely related simian virus analogues named STLV-1, -2, and -3. To assess the risk of cross-species transmissions of STLVs from nonhuman primates to humans in the Democratic Republic of Congo, a total of 330 samples, derived from primate bushmeat, were collected at remote forest sites where people rely on bushmeat for subsistence. STLV prevalences and genetic diversity were estimated by PCR and sequence analysis of tax-rex and LTR fragments. Overall, 7.9% of nonhuman primate bushmeat is infected with STLVs. We documented new STLV-1 and STLV-3 variants in six out of the seven species tested and showed for the first time STLV infection in C. mona wolfi, C. ascanius whitesidei, L. aterrimus aterrimus, C. angolensis, and P. tholloni. Our results provide increasing evidence that the diversity and geographic distribution of PTLVs are much greater than previously thought.
- Published
- 2012
- Full Text
- View/download PDF
13. High HIV type 1 group M pol diversity and low rate of antiretroviral resistance mutations among the uniformed services in Kinshasa, Democratic Republic of the Congo.
- Author
-
Djoko CF, Rimoin AW, Vidal N, Tamoufe U, Wolfe ND, Butel C, LeBreton M, Tshala FM, Kayembe PK, Muyembe JJ, Edidi-Basepeo S, Pike BL, Fair JN, Mbacham WF, Saylors KE, Mpoudi-Ngole E, Delaporte E, Grillo M, and Peeters M
- Subjects
- Adult, Anti-Retroviral Agents therapeutic use, Democratic Republic of the Congo epidemiology, Enzyme-Linked Immunosorbent Assay, Female, Genetic Variation, HIV Infections drug therapy, HIV-1 classification, Humans, Male, Middle Aged, Military Personnel, Molecular Sequence Data, Polymerase Chain Reaction, Drug Resistance, Viral genetics, Genes, pol genetics, HIV Infections epidemiology, HIV Infections genetics, HIV-1 genetics, Mutation
- Abstract
For the first time the genetic diversity among the uniformed personnel in Kinshasa, the capital city of the Democratic Republic of Congo (DRC), a country that has experienced military conflicts since 1998 and in which the global HIV-1/M pandemic started, has now been documented. A total of 94 HIV-1-positive samples, collected in 2007 in Kinshasa garrison settings from informed consenting volunteers, were genetically characterized in the pol region (protease and RT). An extensive diversity was observed, with 51% of the strains corresponding to six pure subtypes (A 23%, C 13.8%, D, G, H, J, and untypable), 15% corresponding to nine different CRFs (01, 02, 11, 13, 25, 26, 37, 43, and 45), and 34% being unique recombinants with one-third being complex mosaic viruses involving three or more different subtypes/CRFs. Only one strain harbored a single mutation, I54V, associated with drug resistance to protease inhibitors. Due to their high mobility and potential risk behavior, HIV infections in military personnel can lead to an even more complex epidemic in the DRC and to a possible increase of subtype C.
- Published
- 2011
- Full Text
- View/download PDF
14. Changes in the renal function after tenofovir-containing antiretroviral therapy initiation in a Senegalese cohort (ANRS 1215).
- Author
-
De Beaudrap P, Diallo MB, Landman R, Guèye NF, Ndiaye I, Diouf A, Kane CT, Etard JF, Girard PM, Sow PS, and Delaporte E
- Subjects
- Adenine administration & dosage, Adenine adverse effects, Adult, Anti-HIV Agents administration & dosage, Antiretroviral Therapy, Highly Active methods, Female, Glomerular Filtration Rate drug effects, HIV Infections virology, HIV-1 isolation & purification, Humans, Incidence, Kidney Function Tests, Male, Middle Aged, Organophosphonates administration & dosage, Senegal, Tenofovir, Adenine analogs & derivatives, Anti-HIV Agents adverse effects, Antiretroviral Therapy, Highly Active adverse effects, HIV Infections drug therapy, Kidney drug effects, Kidney physiology, Organophosphonates adverse effects, Renal Insufficiency chemically induced
- Abstract
To describe and compare the changes in renal function between HIV-1 infected adult patients receiving antiretroviral therapy (ART) with and without tenofovir (TDF). The population consisted of 40 patients starting a TDF-containing regimen and 388 patients starting regimen not containing TDF, and followed during 42 months. The estimated glomerular filtration rate (eGFR) was calculated using the Cockroft-Gault and MDRD equations and modeled separately for the first 12 months and the subsequent period. Between baseline and 12 months, the eGFR decreased significantly in patients receiving TDF (-10.40 ml/min), whereas it increased in the other +4.33 ml/min). A significant variability in the eGFR trajectories of patients receiving TDF was observed; 12 (30%) of them experienced a persistent decrease, 5 (12%) had an initial transient increase, and 23 (58%) a steady slow increase in eGFR. The characteristics at baseline of the patients with persistent decrease were not different from the other patients but their immune reconstitution was impaired. After 12 months, patients receiving TDF experienced a higher rate of transition from mild renal impairment (60-90 ml/min/1.73 m(2)) to moderate renal impairment (30-60 ml/min/1.73 m(2)) when compared with patients not receiving TDF. A significant though moderate decline in the renal function was observed in one-third of the patients receiving TDF compared to patients not receiving TDF. Moreover, this impairment was persistent after the first year of treatment.
- Published
- 2010
- Full Text
- View/download PDF
15. CRF45_AKU, a circulating recombinant from Central Africa, is probably the common ancestor of HIV type 1 MAL and HIV type 1 NOGIL.
- Author
-
Niama FR, Vidal N, Bazepeo SE, Mpoudi E, Toure-Kane C, Parra HJ, Delaporte E, and Peeters M
- Subjects
- Base Sequence, Cameroon epidemiology, Democratic Republic of the Congo epidemiology, Gabon epidemiology, Genetic Variation, HIV Infections virology, HIV-1 genetics, Humans, Molecular Sequence Data, Phylogeny, Recombination, Genetic, Sequence Analysis, DNA, Genome, Viral genetics, HIV Infections epidemiology, HIV-1 classification
- Abstract
Abstract In this study, we characterized four HIV-1 strains from Cameroon, Gabon, and the Democratic Republic of Congo (DRC), collected during independent serosurveys, and previously found to cluster in the pol gene with HIV-1 MAL and HIV-1 NOGIL3, two complex recombinant viruses reported in the early HIV epidemic, and with the recombinant strain 04FR.AUK recently described in France. The four newly sequenced viruses shared the same structure as 04FR.AUK, involving alternating fragments of subtype A, K, and unclassified (U) fragments, representing a new CRF called CRF45_AKU. Some of the unclassified fragments were related to unclassified regions described in either CRF04 or CRF09 strains. Careful reanalysis of HIV-1 MAL and HIV-1 NOGIL3 demonstrated that these strains were related exclusively to CRF45_AKU and either two subtype D fragments for HIV-1 MAL or one subtype H segment for HIV-1 NOGIL3. Following extensive blast searches, related gag, pol, and env sequences were observed in Central and West Africa (Senegal, Mali), as well as in Europe (France, Spain, Italy, Cyprus), Argentina, and China.
- Published
- 2009
- Full Text
- View/download PDF
16. Low prevalence of HIV type 1 drug resistance mutations in untreated, recently infected patients from Burkina Faso, Côte d'Ivoire, Senegal, Thailand, and Vietnam: the ANRS 12134 study.
- Author
-
Ayouba A, Lien TT, Nouhin J, Vergne L, Aghokeng AF, Ngo-Giang-Huong N, Diop H, Kane CT, Valéa D, Rouet F, Joulia-Ekaza D, Toni TD, Nerrienet E, Ngole EM, Delaporte E, Costagliola D, Peeters M, and Chaix ML
- Subjects
- Adult, Burkina Faso epidemiology, Cote d'Ivoire epidemiology, Female, Genotype, HIV Protease genetics, HIV Reverse Transcriptase genetics, HIV-1 genetics, Humans, Molecular Sequence Data, Phylogeny, Pregnancy, Prevalence, Senegal epidemiology, Sequence Analysis, DNA, Thailand epidemiology, Vietnam epidemiology, Young Adult, Anti-HIV Agents therapeutic use, Drug Resistance, Viral genetics, HIV Infections drug therapy, HIV Infections epidemiology, HIV Infections virology, HIV-1 drug effects, Mutation, Pregnancy Complications, Infectious drug therapy, Pregnancy Complications, Infectious epidemiology, Pregnancy Complications, Infectious virology
- Abstract
The frequency of transmitted HIV drug resistance (HIVDR) was evaluated in the context of rapid scale-up of antiretroviral treatment in Thailand, Vietnam, Burkina Faso, Côte d'Ivoire, and Senegal by using an adaptation of the WHO generic protocol of the HIV Drug Resistance Threshold Survey (HIVDR-TS) for sample collection and classification. Resistance-associated mutations were interpreted using the 2009 WHO list for epidemiological surveys. We included 266 subjects from the five study sites. Of the 266 RT and PR sequences analyzed, two from Vietnam harbored virus with major drug resistance mutations (G190A in RT for one individual and M46I in PR for the second individual). Phylogenetic analysis revealed that CRF01_AE predominates (>90%) in Thailand and Vietnam. CRF02 (>65%) cocirculates with other HIV-1 variants in Senegal and Côte d'Ivoire. The prevalence of HIVDRM is scored as low (< or = 5%) in all the five sites for the three drug classes analyzed. A continuous population survey for HIVDRM will provide a rational basis for maintaining or changing the current first line regimen in these countries.
- Published
- 2009
- Full Text
- View/download PDF
17. Genetic characterization of eight full-length HIV type 1 genomes from the Democratic Republic of Congo (DRC) reveal a new subsubtype, A5, in the A radiation that predominates in the recombinant structure of CRF26_A5U.
- Author
-
Vidal N, Bazepeo SE, Mulanga C, Delaporte E, and Peeters M
- Subjects
- DNA, Viral analysis, DNA, Viral genetics, Democratic Republic of the Congo epidemiology, Genetic Variation, Humans, Phylogeny, Sequence Analysis, DNA, env Gene Products, Human Immunodeficiency Virus analysis, env Gene Products, Human Immunodeficiency Virus genetics, Genome, Viral, HIV Infections epidemiology, HIV Infections virology, HIV-1 genetics, Recombination, Genetic
- Abstract
In this study, we characterized HIV-1 strains from the Democratic Republic of Congo (DRC), previously described as divergent subtype A (n = 1, 97CD.KMST91) or untypable (n = 7) in the V3-V5 env region. Four strains had the same structure over the entire genome, including alternating fragments of a new subsubtype, A5, within the subtype A radiation and fragments that remain unclassified. Therefore, the cluster of new viruses represents a new circulating recombinant, CRF26_A5U. Three additional strains were unique recombinants with the newly described CRF26_A5U and subtype C. Finally, the nearly full-length sequence of 97CD.KMST91 showed that this strain also consisted of alternating fragments of a divergent subtype A lineage and unclassified fragments, although different from previously reported A and U sequences. The high genetic distances among the different CRF26-A5U strains suggest their longstanding presence in the DRC.
- Published
- 2009
- Full Text
- View/download PDF
18. Long-term efficacy and tolerance of efavirenz- and nevirapine-containing regimens in adult HIV type 1 Senegalese patients.
- Author
-
de Beaudrap P, Etard JF, Guèye FN, Guèye M, Landman R, Girard PM, Sow PS, Ndoye I, and Delaporte E
- Subjects
- Adult, Alkynes, Anti-HIV Agents adverse effects, Benzoxazines adverse effects, CD4 Lymphocyte Count, Cohort Studies, Cyclopropanes, Drug Tolerance, Female, HIV Infections immunology, HIV Infections mortality, Humans, Logistic Models, Male, Nevirapine adverse effects, Patient Selection, Poisson Distribution, Proportional Hazards Models, Reverse Transcriptase Inhibitors adverse effects, Senegal epidemiology, Time Factors, Treatment Outcome, Viral Load, Anti-HIV Agents therapeutic use, Benzoxazines therapeutic use, HIV Infections drug therapy, HIV-1 drug effects, Nevirapine therapeutic use, Reverse Transcriptase Inhibitors therapeutic use
- Abstract
Owing to their low toxicity, low price, and ease of use, efavirenz (EFV) and nevirapine (NVP) are frequently used as part of antiretroviral regimens for AIDS treatment. Several clinical trials have already studied their efficacy and tolerance. However, long-term observations of the effects of these drugs in patients are limited. We used data from a prospective Senegalese cohort to analyze long-term tolerance and efficacy of these two drugs in a low-resources setting. Patients were included if they started their therapy with EFV or NVP. They were censored after treatment discontinuation. The primary endpoint was the time to treatment discontinuation. Secondary endpoints included time to death, time to disease progression, occurrence of severe adverse effects, CD4 cell recovery, and virological response. Confounding factors were controlled using marginal structural models. The median follow-up time in both EFV and NVP arms was 48 months. The hazard ratio (HR) of drug discontinuation in the EFV arm vs. the NVP arm was 0.84 (0.34; 1.87). There was a borderline difference in virological response [HR 1.38 (0.999; 1.89)] but no differences in time to death [HR 1.15 (0.41; 3.24)], time to AIDS progression [HR 1.25 (0.61; 2.58)], or time to increase in CD4 cell count above 500 cells/mm3. Adverse effects were different between NVP and EFV, but long-term tolerance was good for both. This analysis provided further information on long-term tolerance and efficacy of EFV and NVP in a resource-limited setting.
- Published
- 2008
- Full Text
- View/download PDF
19. Molecular tracing of sexual HIV Type 1 transmission in the southwest border of China.
- Author
-
Bao L, Vidal N, Fang H, Deng W, Chen S, Guo W, Qin C, Peeters M, Delaporte E, Andrieu JM, and Lu W
- Subjects
- Adolescent, Adult, Aged, Child, China epidemiology, Disease Transmission, Infectious, Female, HIV Seropositivity transmission, Humans, Male, Middle Aged, Molecular Epidemiology, Molecular Sequence Data, Needle Sharing, Risk Factors, Sentinel Surveillance, Sexual Behavior, env Gene Products, Human Immunodeficiency Virus genetics, pol Gene Products, Human Immunodeficiency Virus genetics, Contact Tracing, Disease Outbreaks, HIV Seropositivity epidemiology, HIV-1 genetics
- Abstract
Since the first outbreak of HIV-1 was reported in heroin users in China in 1989, HIV-1 has spread steadily among injection drug users, leading to an exponential growth of nationwide outbreaks from 1998 to 2004. However, the impact of sexual transmission on outbreaks of HIV in China's general population is still unclear. Through a governmental HIV/AIDS surveillance program, an HIV serological study was conducted in volunteers between 1996 and 2005 in Xishuangbanna Dai Autonomous Prefecture of Yunnan province. We performed the transmission reconstruction by molecular epidemiological tracing in a subset of the HIV-1-seropositive individuals diagnosed during this survey. Neighbor joining and maximum likelihood trees based on the HIV-1 pol and env genes were implemented to provide information on putative epidemiological links, which were then confirmed by contact tracing. Of 25,390 volunteers, 501 (2%) accumulated cases of HIV-1 infection (21.1% in needle-sharing drug users, 77.3% in heterosexual adults, 0.4% in homosexual adults, and 1.2% in children born from infected mothers) were diagnosed. Among 44 heterosexually infected and antiretroviral-naive local-traceable individuals (27 infected with HIV-1 subtype CRF01_AE, 15 with CRF08_BC, 1 with G, and 1 with a new B/C recombinant), 18 (40.9%) were coclustered into 8 transmission chains with an average size of 2.25 infections per chain. Phylogenetic and epidemiological linkages confirmed eight heterosexual transmission events. This is the first report providing molecular epidemiological evidence of heterosexual transmission of HIV-1 in China's general population. The reconstruction of transmission of current HIV-1 outbreaks by molecular epidemiological tracing is instrumental in identifying sources of the epidemic and in defining prevention strategies.
- Published
- 2008
- Full Text
- View/download PDF
20. Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon.
- Author
-
Laurent C, Bourgeois A, Mpoudi-Ngolé E, Ciaffi L, Kouanfack C, Mougnutou R, Nkoué N, Calmy A, Koulla-Shiro S, and Delaporte E
- Subjects
- Adult, Anemia, CD4 Lymphocyte Count, Cameroon, Cohort Studies, Drug Therapy, Combination, Female, Follow-Up Studies, HIV Infections complications, HIV Infections mortality, HIV-Associated Lipodystrophy Syndrome, Humans, Kaplan-Meier Estimate, Lamivudine adverse effects, Male, Multivariate Analysis, Nevirapine adverse effects, Patient Compliance, Peripheral Nervous System Diseases, Prospective Studies, Stavudine adverse effects, Treatment Outcome, Viral Load, Zidovudine adverse effects, Anti-HIV Agents therapeutic use, HIV Infections drug therapy, Lamivudine therapeutic use, Nevirapine therapeutic use, Stavudine therapeutic use, Zidovudine therapeutic use
- Abstract
We compared the tolerability and effectiveness of two major first-line regimens used in resource-limited settings, namely zidovudine-lamivudine-nevirapine and stavudine-lamivudine-nevirapine. HIV-1-infected adults in Cameroon were enrolled in a prospective cohort study between 2001 and 2003. They were eligible if they had AIDS or a CD4 cell count below 350/mm(3), a Karnofsky score over 50%, and no contraindications to antiretroviral treatment. The patients were followed up to 2 years. Of 169 patients, 85 received zidovudine-lamivudine-nevirapine and 84 stavudine-lamivudine-nevirapine. The incidence rates of treatment changes, death, drug resistance, and severe adverse effects were, respectively, 12.0 [95% confidence interval (CI) 7.2-19.9] and 10.9 (CI 6.4-18.3) per 100 person-years; 5.7 (CI 2.8-11.4) and 7.6 (CI 4.2-13.7); 2.9 (CI 1.1-7.7) and 5.0 (CI 2.4-10.6); and 41.7 (CI 30.2-57.6) and 49.1 (CI 36.1-66.6). The Kaplan-Meier curves for the likelihood of remaining on the initial regimen (p = 0.8) and for survival (p = 0.5) did not differ significantly between the groups. In Cox multivariate analysis only a lower baseline CD4 cell count was associated with death (p < 0.001). The proportion of patients with undetectable viral load and the increase in the CD4 cell count were similar in the two groups. Anemia was rare (4% vs. 6%). Five cases of severe peripheral neuropathy and one case of lipodystrophy occurred. This study suggests that the zidovudine-lamivudine-nevirapine combination is a safe first-line treatment, even in settings with few laboratory resources. In view of stavudine toxicity, these results support recommendations calling for a gradual switch from stavudine- to zidovudine-based regimens.
- Published
- 2008
- Full Text
- View/download PDF
21. Characterization of an old complex circulating recombinant form, CRF27_cpx, originating from the Democratic Republic of Congo (DRC) and circulating in France.
- Author
-
Vidal N, Frange P, Chaix ML, Mulanga C, Lepira F, Bazepeo SE, Goujard C, Meyer L, Rouzioux C, Delaporte E, and Peeters M
- Subjects
- Democratic Republic of the Congo, France, Genome, Viral, HIV-1 genetics, Humans, Molecular Epidemiology, Molecular Sequence Data, Phylogeny, Recombination, Genetic, Sequence Analysis, DNA, HIV Infections virology, HIV-1 classification, HIV-1 isolation & purification
- Abstract
Full-length genomes were characterized for two samples, 02CD-LBR024 from the Democratic Republic of Congo (DRC) and 04FR-CD-KZS from France, that formed a separate subcluster with a previously characterized env subtype E isolate from DRC with a recombinant structure different from CRF01-AE. Since the three viruses are clearly epidemiologically unlinked and share the same complex recombinant structure, they represent a circulating recombinant form, designated as CRF27-cpx. The recombination pattern involves six different HIV-1 subtypes (A, E, G, H, J, and K) and a small unclassified fragment. The genetic distances are relatively high, indicating that CRF27-cpx evolved over a long time. Their prevalence is low (0.75%) and remained stable over time in the DRC. The existence of the 04FR.CD.KZS virus, in a patient who recently seroconverted in France, confirmed that these strains now circulate outside the DRC. Continuous monitoring of HIV-1 strains thus remains important to allow early identification of the introduction of new variants.
- Published
- 2008
- Full Text
- View/download PDF
22. HIV type 1 diversity and antiretroviral drug resistance mutations in Burundi.
- Author
-
Vidal N, Niyongabo T, Nduwimana J, Butel C, Ndayiragije A, Wakana J, Nduwimana M, Delaporte E, and Peeters M
- Subjects
- Base Sequence, Burundi epidemiology, Gene Products, env, Gene Products, pol, Genes, env, Genes, pol, HIV Infections drug therapy, HIV Infections epidemiology, HIV-1 classification, HIV-1 drug effects, Humans, Molecular Sequence Data, Phylogeny, Recombination, Genetic, Anti-Retroviral Agents therapeutic use, Drug Resistance, Viral genetics, Genetic Variation, HIV Infections virology, HIV-1 genetics
- Abstract
In 2002, an HIV surveillance study was performed among more than 5500 individuals representing the general population of urban and rural districts in Burundi. In this report, we genetically characterized a subset of the HIV-1-positive samples identified during this survey, including all the HIV-positive samples from Bujumbura, the capital city, and samples from one semiurban and one rural district. One hundred and nineteen samples were genetically characterized in the V3-V5 region of the env gene and/or in the protease and reverse transcriptase region of the pol gene. Phylogenetic analysis of 101 env/pol sequences revealed that the HIV-1 epidemic in Burundi was driven by subtype C (81.2%), followed by subtype A (7.9 %) and polC/envA recombinants (5.9%). One major mutation associated with resistance to antiretroviral drugs (ARVs) in the pol gene, as defined by the International AIDS Society Resistance Testing-USA panel, was observed in one individual, but many minor resistance-associated mutations were also present in the majority of the samples.
- Published
- 2007
- Full Text
- View/download PDF
23. Phylogenetic analysis of Brazilian HIV type 1 subtype D strains: tracing the origin of this subtype in Brazil.
- Author
-
Couto-Fernandez JC, Eyer-Silva WA, Guimarães ML, Chequer-Fernandez SL, Grinsztejn B, Delaporte E, Peeters M, and Morgado MG
- Subjects
- Brazil, Genes, nef, Genome, Viral, HIV Envelope Protein gp41 genetics, HIV Protease genetics, HIV Reverse Transcriptase genetics, HIV-1 genetics, Integrases genetics, Likelihood Functions, Molecular Sequence Data, HIV-1 classification, Phylogeny
- Abstract
HIV-1 Subtype D occurs mainly in East and Central African countries, especially Uganda, where the prevalence of HIV-1 infection is among the highest in the world. We present the phylogenetic analysis of one nonautochthonous and four autochthonous (including a near full-length genome) Brazilian HIV-1 subtype D strains identified in Rio de Janeiro State, where subtypes B, F1, and BF1 recombinants predominate. Phylogenetic inferences using maximum likelihood were applied on a near-full length genome and on concatenated gag, protease, reverse transcriptase, integrase, C2V3/env, gp41, and nef segments. Sequences from an Angolan immigrant showed close genetic similarity with a strain described in Finland, from an HIV patient of African origin, whereas all four autochthonous Brazilian sequences clustered with South African strains, where subtype D occurs only in isolated cases. Our results suggest the successful introduction and circulation in Brazil of closely related HIV-1 subtype D strains, possibly of South African origin.
- Published
- 2006
- Full Text
- View/download PDF
24. Presence of CRF09_cpx and complex CRF02_AG/CRF09_cpx recombinant HIV type 1 strains in Côte d'Ivoire, West Africa.
- Author
-
Toni T, Adjé-Touré C, Vidal N, Minga A, Huet C, Borger MY, Recordon-Pinson P, Masquelier B, Nolan M, Nkengasong J, Fleury HJ, Delaporte E, and Peeters M
- Subjects
- Cote d'Ivoire, Gene Products, env genetics, Gene Products, pol genetics, HIV-1 classification, Molecular Sequence Data, Species Specificity, HIV-1 genetics
- Abstract
Based on partial env and pol (protease and RT) subtyping, we recently documented that the majority (>80%) of the HIV-1 strains that circulate in Côte d'Ivoire were CRF02_AG and about 11% were recombinants or could not be clearly assigned to a known subtype or CRF. In order to determine in more detail the precise structure of these viruses we sequenced the full-length genomes for six such strains. Bootscan and phylogenetic tree analysis showed that four strains were complex and unique CRF02_AG/CRF09_cpx recombinants, one was a CRF02_AG/CRF06_cpx recombinant, and one was a pure CRF09_cpx. Reanalysis of the remaining recombinants asserted the predominance of CRF09_cpx within intersubtype recombinants and circulation of CRF09_cpx in Côte d'Ivoire. More detailed analysis of the CRF09_cpx strains revealed also that part of the pol gene belonged to subtype K. This is the first time that such recombinants are described.
- Published
- 2005
- Full Text
- View/download PDF
25. Enfuvirtide binding domain is highly conserved in non-B HIV type 1 strains from Cameroon, West Central Africa.
- Author
-
Aghokeng AF, Ewane L, Awazi B, Nanfack A, Delaporte E, Zekeng L, and Peeters M
- Subjects
- Amino Acid Sequence, Cameroon, Conserved Sequence, Enfuvirtide, HIV Envelope Protein gp41 genetics, HIV Envelope Protein gp41 pharmacology, HIV Fusion Inhibitors pharmacology, HIV Infections drug therapy, HIV Infections virology, HIV-1 classification, HIV-1 drug effects, HIV-1 genetics, Humans, Molecular Sequence Data, Peptide Fragments pharmacology, Recombination, Genetic, Sequence Analysis, DNA, HIV Envelope Protein gp41 chemistry, HIV Envelope Protein gp41 metabolism, HIV Fusion Inhibitors metabolism, HIV-1 metabolism, Peptide Fragments metabolism
- Abstract
Recently T-20 or enfuvirtide, the first drug of a new class of antiretrovirals targeting the entry stage of the virus life cycle, has been clinically approved. Enfuvirtide is a peptide derived from the HR2 region of the transmembrane glycoprotein from the HXB2 HIV-1 subtype B prototype strain that binds to the HR1 region. Drug resistance seems to occur in the HR1 region between amino acids 36 and 45. We examined to what extent this region is conserved in 184 non-B strains from Cameroon: 132 (71.7%) CRF02-AG, 14 (7.6%) subtype A, 11 (5.9%) F2, 9 (4.8%) subtype D, 8 (4.3%) subtype G, 4 (2.1%) CRF01-AE, 4 (2.1%) CRF11-cpx, and 2 (1.1%) CRF06-cpx. Among the 184 strains studied, no amino acid mutation was found in the highly conserved three amino acid motif at codons 36-38 (GIV) that are important determinants of viral susceptibility to enfuvirtide. Other common substitutions like Q40H and N42T were also absent. The N42S polymorphism was present in 148 (80.4%) strains. Analysis of the HR2 domain, from which the peptide is derived, indicated a much greater genetic variability as compared to HR1.
- Published
- 2005
- Full Text
- View/download PDF
26. Complete genome analysis of one of the earliest SIVcpzPtt strains from Gabon (SIVcpzGAB2).
- Author
-
Bibollet-Ruche F, Gao F, Bailes E, Saragosti S, Delaporte E, Peeters M, Shaw GM, Hahn BH, and Sharp PM
- Subjects
- Animals, Molecular Sequence Data, Phylogeny, RNA, Viral analysis, Simian Acquired Immunodeficiency Syndrome epidemiology, Simian Acquired Immunodeficiency Syndrome virology, Simian Immunodeficiency Virus classification, Genome, Viral, Pan troglodytes virology, Simian Immunodeficiency Virus genetics
- Abstract
Chimpanzees in west central Africa (Pan troglodytes troglodytes) are known to harbor simian immunodeficiency viruses (SIVcpzPtt) that represent the closest relatives of human immunodeficiency virus type 1 (HIV-1); however, the number of SIVcpzPtt strains that have been fully characterized is still limited. Here, we report the complete nucleotide sequence of SIVcpzGAB2, a virus originally identified in 1989 in a chimpanzee (P. t. troglodytes) from Gabon. Analysis of this sequence reveals that SIVcpzGAB2 is a member of the SIVcpzPtt group of viruses, but that it differs from other SIVcpzPtt strains by exhibiting a highly divergent Env V3 loop with an unusual crown (NLSPGTT) containing a canonical N-linked glycosylation site, an unpaired cysteine residue in Env V4, and two late (L) domain motifs (PTAP and YPSL) in Gag p6. Moreover, phylogenetic analyses indicate evidence of recombination during the early divergence of SIVcpzPtt strains; in particular, part of the pol gene sequence of SIVcpzGAB2 appears to be derived from a previously unidentified SIVcpz lineage ancestral to HIV-1 group O. These data indicate extensive diversity among naturally occurring SIVcpzPtt strains and provide new insight into the origin of HIV-1 group O.
- Published
- 2004
- Full Text
- View/download PDF
27. Emergence of complex and diverse CRF02-AG/CRF06-cpx recombinant HIV type 1 strains in Niger, West Africa.
- Author
-
Mamadou S, Vidal N, Montavon C, Ben A, Djibo A, Rabiou S, Soga G, Delaporte E, Mboup S, and Peeters M
- Subjects
- Genome, Viral, HIV-1 genetics, Humans, Molecular Sequence Data, Niger epidemiology, Phylogeny, Sequence Analysis, DNA, HIV Infections epidemiology, HIV Infections virology, HIV-1 classification, Recombination, Genetic
- Abstract
On the basis of partial env and gag subtyping, we documented that the majority of HIV-1 strains circulating in Niger were CRF02-AG (54.3%) or CRF06-cpx (18.1%) and that 9% of the samples were possible recombinants between CRF02 and CRF06. To determine in more detail the precise structure of these viruses we sequenced the full-length genomes for three such strains (97NE-003, 00NE-036, and 00NE-095). From the bootscan and phylogenetic tree analysis it is evident that the new viruses are the result of recombination events between CRF02-AG and CRF06-cpx strains. Importantly, each virus had a different complex recombinant structure with multiple breakpoints, leading to viruses with complex mosaic patterns.
- Published
- 2003
- Full Text
- View/download PDF
28. Predominance of CRF02-AG and CRF06-cpx in Niger, West Africa.
- Author
-
Mamadou S, Montavon C, Ben A, Djibo A, Rabiou S, Mboup S, Delaporte E, and Peeters M
- Subjects
- Adolescent, Adult, Base Sequence, Female, Genes, env, Genes, gag, HIV Core Protein p24 genetics, HIV-1 genetics, Humans, Male, Middle Aged, Molecular Sequence Data, Nigeria, HIV-1 classification
- Abstract
A total of 110 HIV-1-positive samples obtained in 1997 (n = 44) and 2000 (n = 66) were genetically characterized in the V3-V5 envelope region and the p24 gag region. The majority of the strains were CRF02-AG (54.3%) or CRF06-cpx (18.1%) in env and gag. More than 9% of the samples were recombinants between CRF02 and CRF06; 9 were CRF06 in env but CRF02 in gag, and for one sample the opposite was seen. Overall for 23 (20.9%) samples, the subtype designation was different between env and gag, and in 20 of these 23 samples a CRF was involved in the recombination event. No significant differences were seen between subtype distributions in 1997 and 2000, except that the proportion of recombinants increased from 13.6% in 1997 to 27.2% in 2000.
- Published
- 2002
- Full Text
- View/download PDF
29. Identification of a new circulating recombinant form of HIV type 1, CRF11-cpx, involving subtypes A, G, J, and CRF01-AE, in Central Africa.
- Author
-
Montavon C, Vergne L, Bourgeois A, Mpoudi-Ngole E, Malonga-Mouellet G, Butel C, Toure-Kane C, Delaporte E, and Peeters M
- Subjects
- Base Sequence, Cameroon epidemiology, Central African Republic epidemiology, DNA, Viral, Genes, env, Genes, nef, Genes, pol, HIV Infections epidemiology, Humans, Molecular Sequence Data, Phylogeny, Recombination, Genetic, Genome, Viral, HIV Infections virology, HIV-1 genetics
- Abstract
In this study, we characterized three full-length genome sequences with a similar mosaic structure from epidemiologically unlinked individuals from Cameroon (97CM-MP818) and the Central African Republic (99CF-MP1298 and 99CF-MP1307). Phylogenetic and recombinant analysis confirmed that the three strains had a similar complex recombinant genome, which we can designate now as CRF11-cpx. This new CRF was composed of successive fragments of subtype A, G, J, and CRF01-AE. The previously reported GR17 virus from a Greek patient infected in the Democratic Republic of Congo (DRC) has a similar structure and should be considered as the prototype strain of CRF11-cpx. This new CRF circulates in Cameroon, Central African Republic, Gabon, and DRC, although the exact prevalences remain to be determined.
- Published
- 2002
- Full Text
- View/download PDF
30. Full-length genome sequencing of HIV type 1 group O viruses isolated from a heterosexual transmission cluster in Senegal.
- Author
-
Kane CT, Montavon C, Toure MA, Faye MA, Ndiaye AG, Diallo AG, Ndoye I, Liegeois F, Delaporte E, Mboup S, and Peeters M
- Subjects
- Female, HIV Infections virology, HIV-1 isolation & purification, Heterosexuality, Humans, Male, Molecular Sequence Data, Phylogeny, Senegal, Sequence Analysis, DNA, Genome, Viral, HIV Infections transmission, HIV-1 classification, HIV-1 genetics
- Abstract
In a polygamous marriage in Senegal, the husband and his two spouses were infected with HIV-1 group O. This study provides new full-length genome sequences for the two spouses (99SE-MP1299 and 99SE-MP1300) and the 3'-end LTR-tat fragment (6084 bp) for the husband (98SE-42HALD). Phylogenetic tree and diversity plot analysis revealed that the new viruses belong to HIV-1 group O and that they are closely related to each other in a cluster around ANT-70. The intrafamilial transmission occurred at most 6 years ago. The interpatient variability was highest in the envelope region, and in some regions of the envelope the strains from the two spouses do not cluster together anymore. The source of infection was in Cameroon and confirms a slow but continuous spread of HIV-1 group O viruses.
- Published
- 2001
- Full Text
- View/download PDF
31. Identification of a complex env subtype E HIV type 1 virus from the democratic republic of congo, recombinant with A, G, H, J, K, and unknown subtypes.
- Author
-
Vidal N, Mulanga-Kabeya C, Nzilambi N, Delaporte E, and Peeters M
- Subjects
- Democratic Republic of the Congo, Humans, Molecular Sequence Data, Phylogeny, Sequence Analysis, DNA, Genes, env genetics, Genome, Viral, HIV Infections virology, HIV-1 classification, HIV-1 genetics, Recombination, Genetic
- Abstract
Up to now, all known env subtype E viruses (CRF01-AE) have had the same mosaic structure with subtype A, and no other env subtype E HIV-1 viruses with non-A subtypes in their genomes have been described. In this report we describe the full-length genome sequence of an env subtype E isolate with a recombinant genome different from the prototype CRF01-AE strains. The 97CD-KTB49 strain, obtained from a tuberculosis patient in Kinshasa, has a complex mosaic genome involving subtypes A, E, G, H, J, K, and several unknown fragments. The U sequences formed well-separated clusters together with previously described unknown fragments from CRF04-cpx (subtype I), and from Z321, the oldest intersubtype recombinant isolated in 1976 in the Democratic Republic of Congo. The complex recombinant virus from our study is not an isolated strain; partial sequencing of a second strain, 97CD-KFE45, confirmed the breakpoints observed in the 97CD-KTB49 strain in the regions sequenced. The complexity of these recombinant strains suggests a longstanding presence of subtype E in Central Africa.
- Published
- 2000
- Full Text
- View/download PDF
32. Identification of all HIV type 1 group M subtypes in Senegal, a country with low and stable seroprevalence.
- Author
-
Toure-Kane C, Montavon C, Faye MA, Gueye PM, Sow PS, Ndoye I, Gaye-Diallo A, Delaporte E, Peeters M, and Mboup S
- Subjects
- Adolescent, Adult, Aged, Base Sequence, Female, Genes, Viral genetics, Genes, env genetics, Genes, gag genetics, Humans, Longitudinal Studies, Male, Middle Aged, Molecular Epidemiology, Molecular Sequence Data, Phylogeny, Senegal epidemiology, Seroepidemiologic Studies, HIV Infections epidemiology, HIV-1 genetics
- Abstract
A total of 343 HIV-1-positive samples obtained between June 1996 and March 1999 was genetically characterized in the envelope region by HMA and/or sequencing. The env subtype distribution was as follows: 290 (84.6%) A, 22 (6.5%) B, 16 (4.7%) C, 8 (2.5%) D, 1 (0.03%) E, 1 (0.03%) F1, 4 (1.2%) G, and 1 (0.03%) H. For 77 samples the p24 region from the gag gene was also sequenced, and for 9 (11.6%) the subtypes between env and gag were different. Phylogenetic tree analysis showed the predominance of AG-IBNG-like viruses among gag and env subtype A sequences. HMA is relatively simple and requires less sophisticated technical facilities compared with sequencing, and in Senegal 323 (94.2%) of the 343 samples could be identified by this technique. However, in the actual configuration of the assay, discrimination between the recombinant AG-IBNG-like recombinant viruses, which are predominant in Senegal, and the nonrecombinant subtype A viruses is not possible.
- Published
- 2000
- Full Text
- View/download PDF
33. Predominance of subtype A and G HIV type 1 in Nigeria, with geographical differences in their distribution.
- Author
-
Peeters M, Esu-Williams E, Vergne L, Montavon C, Mulanga-Kabeya C, Harry T, Ibironke A, Lesage D, Patrel D, and Delaporte E
- Subjects
- Adolescent, Adult, Female, Genes, env, Genes, gag, Heteroduplex Analysis, Humans, Male, Middle Aged, Molecular Epidemiology, Molecular Sequence Data, Nigeria epidemiology, Phylogeny, Prevalence, Sequence Analysis, DNA, HIV Infections epidemiology, HIV Infections virology, HIV-1 classification, HIV-1 genetics
- Abstract
The purpose of this study was to generate data on the relative prevalences of the HIV-1 subtypes circulating in Nigeria. A total of 252 HIV-1-positive samples collected during an epidemiologic survey conducted in April 1996 were genetically characterized by HMA (heteroduplex mobility assay) and/or sequencing. Samples were collected in Lagos, Calabar, Kano, and Maiduguri. Overall, the predominant env subtypes were A (61.3%) and G (37.5%). Subtype A is more prevalent in the south (p < 0.001), about 70% in Lagos and Calabar, whereas a quarter of the samples was classified as subtype G in these states. In contrast, subtype G is predominant in the north ( < 0.001), representing 58% of the samples in Kano. In the northeastern region, Maiduguri, almost similar proportions of subtype A and G were seen, 49 and 47.4%, respectively. A total of 37 samples was also sequenced in the p24 region from the gag gene; 13 (35%) had discordant subtype designations between env and gag. The majority of the gag (12 of 17) and env (14 of 22) subtype A sequences clustered with the A/G-IBNG strain. Within subtype G, three different subclusters were seen among the envelope sequences. These different subclusters are observed among samples obtained from asymptomatic individuals and AIDS patients from the four Nigerian states studied. In conclusion, we observed a limited number of HIV-1 subtypes circulating in Nigeria, with subtypes A and G being the major env subtypes responsible for the HIV-1 epidemic. Nevertheless, the high rate of recombinant viruses (A/G) and the different A/G recombinant structures indicate a complex pattern of HIV-1 viruses circulating in this country.
- Published
- 2000
- Full Text
- View/download PDF
34. Near-full-length genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K.
- Author
-
Triques K, Bourgeois A, Vidal N, Mpoudi-Ngole E, Mulanga-Kabeya C, Nzilambi N, Torimiro N, Saman E, Delaporte E, and Peeters M
- Subjects
- Africa, Fusion Proteins, gag-pol genetics, HIV Envelope Protein gp160 genetics, HIV-1 classification, HIV-1 isolation & purification, Humans, Molecular Sequence Data, Phylogeny, Genome, Viral, HIV-1 genetics
- Abstract
We recently reported a high divergence among African subtype F strains. Three well-separated groups (F1, F2, and F3) have been shown based on the phylogenetic analysis of the p24 gag and envelope sequences with genetic distances similar to those observed for known subtypes. In this study, we characterized the near-full-length genomes of two strains from epidemiological unlinked individual belonging to each of the subgroups: F1 (96FR-MP411), F2 (95CM-MP255 and 95CM-MP257), and F3 (96CM-MP535 and 97ZR-EQTB11). Phylogenetic analysis of the near-full-length sequences and for each of the genes separately showed the same three groups, supported by high bootstrap values. Diversity plotting, BLAST subtyping, and bootstrap plotting confirmed that the divergent F strains correspond to nonrecombinant viruses. The divergence between F1 and F2 is consistently lower than that seen in any other intersubtype comparison, with the exception of subtypes B and D. Based on all the different analyses, we propose to divide subtype F into two subclades, with F1 gathering the known subtype F strains from Brazil and Finland, and our African strain (96FR-MP411), and F2 containing the 95CM-MP255 and 95CM-MP257 strains from Cameroon. The F3 strains, 97ZR-EQTB11 from the Democratic Republic of Congo and 96CM-MP535 from Cameroon, meet the criteria of a new subtype designated as K. The equidistance of subtype K to the other subtypes of HIV-1 suggests that this subtype existed as long as the others, the lower distance between B and D, and between F1 and F2 suggest a more recent subdivision for these latter strains.
- Published
- 2000
- Full Text
- View/download PDF
35. The identification of a complex A/G/I/J recombinant HIV type 1 virus in various West African countries.
- Author
-
Montavon C, Bibollet-Ruche F, Robertson D, Koumare B, Mulanga C, Esu-Williams E, Toure C, Mboup S, Saman E, Delaporte E, and Peeters M
- Subjects
- Burkina Faso epidemiology, Evolution, Molecular, Genetic Variation, HIV Infections epidemiology, HIV-1 classification, HIV-1 genetics, Humans, Mali epidemiology, Molecular Sequence Data, Phylogeny, Recombination, Genetic, Genome, Viral, HIV Infections virology, HIV-1 isolation & purification
- Abstract
In this sequence note we describe the full-length genome sequence of an HIV-1 isolate originating from the west African country of Mali. The phylogenetic tree analysis from the near full-length genome shows that the 95ML84 strain forms a separate cluster, supported by 100% of the bootstrap values, with the previously described A/G/J/? mosaic virus BFP90 from Burkina Faso. Additional analysis showed that throughout the genome the lowest diversity was seen between the 95ML84 and the BFP90 viruses, and bootscan analysis showed a similar complex genomic structure. In addition to the initial report describing the BFP90 virus as an A/G/J/? recombinant, our data show that for the BFP90 and 95ML84 strains the unclassified region corresponds to subtype I. The A/G/I/J BFP90 and 95ML84 strains represent the fifth and most complex circulating recombinant form of HIV-1 detected so far, and our data show its presence in various West African countries. Subtype I and J sequences, initially considered rare, seem to have broadened their geographical spread by way of these recombinant forms.
- Published
- 1999
- Full Text
- View/download PDF
36. Genetic characterization of the nef gene from human immunodeficiency virus type 1 group M strains representing genetic subtypes A, B, C, E, F, G, and H.
- Author
-
Jubier-Maurin V, Saragosti S, Perret JL, Mpoudi E, Esu-Williams E, Mulanga C, Liegeois F, Ekwalanga M, Delaporte E, and Peeters M
- Subjects
- Amino Acid Sequence, Consensus Sequence, DNA, Viral analysis, Genes, env genetics, Genetic Variation, HIV-1 isolation & purification, Humans, Molecular Sequence Data, Phylogeny, Sequence Analysis, DNA, Genes, nef genetics, HIV Infections virology, HIV-1 classification, HIV-1 genetics
- Abstract
Most efforts to characterize sequence variation of HIV isolates has been directed toward the structural envelope gene. Few studies have evaluated the sequence variability of auxiliary genes such as nef. In this study 41 new HIV-1 strains, representing the majority of the described envelope subtypes of HIV-1 (A to H), were genetically characterized in the nef region. Phylogenetic analysis showed that 34 strains could be classified in the same subtype in nef and env, and 7 (19%) of the 41 new viruses were recombinants. For two of the seven strains, recombination occurred upstream of the nef gene, whereas for five of the seven strains recombination occurred within the nef gene with a crossover close to the 5' end of the LTR (long terminal repeat). The low intersubtype distance between subtype B and D in the nef gene confirms previous observations in the pol, env, and gag genes, which suggest a common ancestor for these subtypes. The majority of all the previously described functional domains in the nef gene were relatively conserved among the different subtypes, with only minor differences being observed. The myristoylation signal among the different subtypes, with only minor differences being observed. The myristoylation signal was less conserved for subtype C, with one or more amino acid changes being observed at positions 3, 4, and 5. The highly conserved acidic region (positions 62 to 65), critical for the enhancement of viral synthesis with an increased virus growth rate, was less conserved among the subtype G strains from our study. At least three epitopic regions of the nef gene have been defined and each can be recognized by CTLs under a variety of HLA restrictions; all were also relatively well conserved between the different genetic subtypes. Despite the relatively important genetic variation in nef sequences obtained among the different genetic subtypes, functional domains and CTL epitopes were relatively well conserved. In vitro and/or in vivo studies are necessary to study the relevance of the observed differences.
- Published
- 1999
- Full Text
- View/download PDF
37. Molecular characterization of the envelope transmembrane glycoprotein of 13 new human immunodeficiency virus type 1 group O strains from six different African countries.
- Author
-
Bibollet-Ruche F, Peeters M, Mboup S, Ekaza E, Gandji R, Torimiro J, Mpoudi EN, Amblard J, Dibanga G, Saidou M, Esu-Williams E, Vanden Haesevelde M, Saman E, and Delaporte E
- Subjects
- Africa epidemiology, Amino Acid Sequence, DNA, Viral analysis, HIV Infections epidemiology, Humans, Molecular Sequence Data, RNA, Viral analysis, Reverse Transcriptase Polymerase Chain Reaction, Serotyping, HIV Envelope Protein gp41 genetics, HIV Infections virology, HIV-1 classification, HIV-1 genetics
- Published
- 1998
- Full Text
- View/download PDF
38. Genetic characterization of accessory genes from human immunodeficiency virus type 1 group O strains.
- Author
-
Bibollet-Ruche F, Loussert-Ajaka I, Simon F, Mboup S, Ngole EM, Saman E, Delaporte E, and Peeters M
- Subjects
- Amino Acid Sequence, Base Sequence, Consensus Sequence, DNA, Viral analysis, Female, Gene Products, tat chemistry, Gene Products, tat genetics, Gene Products, vif chemistry, Gene Products, vif genetics, Gene Products, vpr chemistry, Gene Products, vpr genetics, HIV Infections virology, Human Immunodeficiency Virus Proteins, Humans, Male, Molecular Sequence Data, Phylogeny, Polymerase Chain Reaction methods, Sequence Analysis, DNA, Viral Regulatory and Accessory Proteins chemistry, Viral Regulatory and Accessory Proteins genetics, tat Gene Products, Human Immunodeficiency Virus, vif Gene Products, Human Immunodeficiency Virus, vpr Gene Products, Human Immunodeficiency Virus, Genes, Viral, HIV-1 classification, HIV-1 genetics
- Abstract
Human immunodeficiency virus type 1 (HIV-1) group O strains have been described as highly divergent, compared with the vast majority of the viruses involved in the worldwide AIDS pandemic, classified in group M. To gain new insights into the diversity and genetic characteristics of group O, we have sequenced the accessory gene region (from vif to vpu) of 14 isolates. Analyses of the deduced amino acid sequences for Vif, Vpr, the first exon of Tat, and Vpu indicate that most of the functional domains of these proteins, as described for group M viruses, are highly conserved and retained among all the group O strains we have characterized. The only difference concerns the Vif phosphorylation sites, which are absent in all of the group O isolates we have sequenced; in contrast, they are well conserved in nearly all of the group M isolates, in which they play critical roles in the regulation of viral replication and infectivity. As already observed for group M isolates, the Vpu protein is also highly diverse among group O strains. Phylogenetic analyses of these sequences indicate that HIV-1 group O can be separated into four different clusters, containing most of the strains we have characterized (except one, which clusters outside of the analyzed viruses). Taking into account the criteria used for clades in group M, we were not able to define group O clades definitively.
- Published
- 1998
- Full Text
- View/download PDF
39. Multiply spliced env and nef transcripts of simian immunodeficiency virus from West African green monkey (SIVagm-sab).
- Author
-
Bibollet-Ruche F, Cuny G, Pourrut X, Brengues C, Galat-Luong A, Galat G, and Delaporte E
- Subjects
- Animals, Base Sequence, DNA, Complementary biosynthesis, DNA, Complementary genetics, DNA, Recombinant, Imino Acids, Molecular Sequence Data, Sequence Alignment, Chlorocebus aethiops virology, Gene Products, env genetics, Gene Products, nef genetics, Simian Immunodeficiency Virus genetics
- Abstract
We have characterized the spliced transcripts of nef and envelope genes of SIVagm from African green monkey of the sabaeus subspecies. Most of the transcripts we have studied, representing the most abundant mRNA species in our assay, have undergone a specific splicing event that removes a part of the trans-activation response (TAR) element. This region is predicted to form a stable secondary structure (four stem-loop elements in SIVagm-sab) that affects the trans-activation of viral gene expression by Tat and the translation of the viral transcripts. Contrary to what is observed in other viruses, in which this R-region splicing has also been described (e.g., HIV-2), the LTR splicing in SIVagm-sab removes part of the first stem-loop and the following ones, nearly completely disrupting the TAR element secondary structure. Because LTR splicing seems to be a conserved feature among the strains we have characterized, these results suggest that this phenomenon could have important consequences for virus replication, pathogenicity, and latency.
- Published
- 1998
- Full Text
- View/download PDF
40. Genetic subtypes of HIV type 1 and HIV type 2 strains in commercial sex workers from Bamako, Mali.
- Author
-
Peeters M, Koumare B, Mulanga C, Brengues C, Mounirou B, Bougoudogo F, Ravel S, Bibollet-Ruche F, and Delaporte E
- Subjects
- Adolescent, Adult, Female, HIV Infections epidemiology, Humans, Mali epidemiology, Middle Aged, Phylogeny, HIV-1 genetics, HIV-2 genetics, Sex Work
- Abstract
In Africa the highest HIV infection rate has been reported among female commercial sex workers (CSWs) who are at increasing risk of acquiring and transmitting HIV infection. In October 1995, 176 CSWs were studied in Bamako, the capital city of Mali. The ages of the CSWs ranged from 15 to 50 years old (mean, 28.8 years). Only 20.45% of the 176 CSWs were Malian; the majority were from Nigeria (32.9%) and Ghana (31.8%), and the remaining were from other African countries. Forty-one percent were active for less than 1 year as a commercial sex worker, and the length of prostitution for the remaining women ranged from 1 to 15 years (mean, 2.76). A total of 81 (46.02%) of the 176 CSWs were positive for HIV antibodies; 63 (35.8%) were HIV-1 positive, (3.9%) were HIV-2 positive, 11 (6.2%) had antibodies to HIV-1 and HIV-2, and none of them had antibodies to group O viruses. For all HIV antibody-positive samples, PBMCs were separated and genetic subtypes of HIV-1 were determined using the heteroduplex mobility assay (HMA), with ED5-ED12 as outer and ES7-ES8 as inner primers. Among the 66 HIV-1 strains characterized, 53 (80.3%) were subtype A, 2 (3.1%) belonged to subtype C, 1 (1.5%) belonged to subtype D, and 10 (15.1%) were identified as subtype G. Among the 10 subtype G strains, 8 were obtained from women who were very recent CSWs, with an activity of 1 year or less, assuming that there is a high probability that these infections occurred recently. Genetic subtypes of five HIV-2 viruses were determined by sequencing of the env and/or gag genes followed by phylogenetic analysis, and all of them belonged to subtype A. Comparison of HIV-1 and HIV-2 seroprevalence data from our study with previous data from Mali shows a significant rise in HIV-1 prevalence and a significant decrease in HIV-2 prevalence and confirms similar trends observed in neighboring countries. We have found four different genetic subtypes of HIV-1; however, subtype A is predominant and accounts for 80% of the cases and 15% of the HIV-1 infections were subtype G. It is important to continue the surveillance of subtypes on a systematic basis in order to see to what extent the proportions of the different subtypes will change over time.
- Published
- 1998
- Full Text
- View/download PDF
41. Isolation of simian immunodeficiency viruses from two sooty mangabeys in Côte d'Ivoire: virological and genetic characterization and relationship to other HIV type 2 and SIVsm/mac strains.
- Author
-
Peeters M, Janssens W, Fransen K, Brandful J, Heyndrickx L, Koffi K, Delaporte E, Piot P, Gershy-Damet GM, and van der Groen G
- Subjects
- Acquired Immunodeficiency Syndrome blood, Acquired Immunodeficiency Syndrome virology, Animals, Antibodies, Viral blood, Base Sequence, Belgium, Chlorocebus aethiops virology, Cote d'Ivoire, DNA Primers, Erythrocebus patas virology, Ghana, HIV Antibodies blood, Humans, Molecular Sequence Data, Papio virology, Polymerase Chain Reaction, Senegal, Simian Immunodeficiency Virus classification, Cercocebus atys virology, HIV-2 genetics, Phylogeny, Simian Immunodeficiency Virus genetics, Simian Immunodeficiency Virus isolation & purification
- Abstract
Objective: To search for the presence of SIV in sooty mangabeys and other monkey species in Côte d'Ivoire, West Africa, and to compare viral isolates with HIV-2 strains from the same region., Methods: Forty-three captive housed monkeys (28 African green monkeys, 6 sooty mangabeys, 6 baboons, and 6 patas monkeys) were tested for the presence of HIV and SIV antibodies. Virus was isolated from the peripheral blood lymphocytes of seropositive animals and from HIV-2 antibody-positive patients originating from Côte d'Ivoire, Ghana, Senegal, and Belgium. Viruses were characterized by Western blot and radioimmunoprecipitation assay. Proviral DNA was amplified by PCR, cloned, and sequenced to construct a phylogenetic tree., Results: One African green monkey and three sooty mangabeys had antibodies that cross-reacted with HIV-2. From two mangabeys lentiviruses were isolated and designated as SIVsmCI2 and SIVsmCI8. Serological, virological, and sequence data showed that these isolates are members of the HIV-2/SIVsm/SIVmac group of primate lentiviruses. Furthermore, in the phylogenetic tree, these two new viruses form a distinct subgroup that is equidistant to the HIV-2 strains and the previously described SIVsm/SIVmac viruses., Conclusion: This study provides additional evidence that sooty mangabey monkeys can be infected with a lentivirus in their natural habitat. Within the SIVsm and SIVmac viruses extensive genetic variation is observed.
- Published
- 1994
- Full Text
- View/download PDF
42. Genetic and antigenic variability of HIV type 1 in Brazil.
- Author
-
Couto-Fernandez JC, Janssens W, Heyndrickx L, Motte J, Fransen K, Peeters M, Delaporte E, Galvão-Castro B, Piot P, and van der Groen G
- Subjects
- Acquired Immunodeficiency Syndrome blood, Amino Acid Sequence, Brazil, Enzyme-Linked Immunosorbent Assay, Gene Products, env chemistry, Genetic Variation, Genotype, Geography, HIV Antibodies immunology, HIV-1 immunology, HIV-1 isolation & purification, Humans, Molecular Sequence Data, Acquired Immunodeficiency Syndrome virology, Gene Products, env genetics, Genes, env, HIV-1 genetics, Phylogeny
- Abstract
Six Brazilian strains of human immunodeficiency virus type 1 (HIV-1) were isolated from infected individuals residing in different regions of Brazil between 1987 and 1989. Phylogenetic analysis based on an 860-base pair env fragment, including V3, V4, V5, and the beginning of gp41, classified the Brazilian strains significantly in genotype B, with interhost distances between 5.9 and 13.1% (mean value, 10%). Amino acid sequence analysis of the V3 loop revealed that three strains contained the North American/European GPGR motif as the tip of the loop whereas in the other three strains proline (P) was substituted by tryptophan (W), methionine (M), or phenylalanine (F). A consensus peptide, Bra-cons, was designed containing GWGR as the tip of the loop. Serological reactivity to the Bra-cons peptide and other V3 peptides (MN, SF2, HBX2, RF, MAL, ELI, Z6, and a Côte d'Ivoire peptide, CI-cons) was compared for 114 HIV-1-positive sera from Rio de Janeiro. Sixty-nine sera (60.5%) reacted with peptides belonging to genotype B, of which 10 sera also reacted with peptides belonging to genotype A (n = 7) and D (n = 3). Eighteen sera (15.8%) had binding antibodies to the Bra-cons peptide. A high number of sera (n = 43; 37.7%) had no antibodies to any of the V3 peptides tested. This result suggests that HIV-1 variants with aberrant V3 loops may circulate in Rio de Janeiro.
- Published
- 1994
- Full Text
- View/download PDF
43. HTLV-II among pygmies from Cameroon.
- Author
-
Froment A, Delaporte E, Dazza MC, and Larouzé B
- Subjects
- Adolescent, Adult, Aged, Cameroon epidemiology, Child, Child, Preschool, Ethnicity, Female, HTLV-I Antibodies blood, HTLV-II Antibodies blood, HTLV-II Infections diagnosis, HTLV-II Infections ethnology, Humans, Infant, Male, Middle Aged, HTLV-II Infections epidemiology
- Published
- 1993
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.